IBDEI07D ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,2947,1,3,0)
 ;;=3^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,2947,1,4,0)
 ;;=4^A60.04
 ;;^UTILITY(U,$J,358.3,2947,2)
 ;;=^5000356
 ;;^UTILITY(U,$J,358.3,2948,0)
 ;;=B39.3^^7^84^57
 ;;^UTILITY(U,$J,358.3,2948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2948,1,3,0)
 ;;=3^Histoplasmosis,Disseminated
 ;;^UTILITY(U,$J,358.3,2948,1,4,0)
 ;;=4^B39.3
 ;;^UTILITY(U,$J,358.3,2948,2)
 ;;=^5000635
 ;;^UTILITY(U,$J,358.3,2949,0)
 ;;=B39.2^^7^84^58
 ;;^UTILITY(U,$J,358.3,2949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2949,1,3,0)
 ;;=3^Histoplasmosis,Pulmonary
 ;;^UTILITY(U,$J,358.3,2949,1,4,0)
 ;;=4^B39.2
 ;;^UTILITY(U,$J,358.3,2949,2)
 ;;=^5000634
 ;;^UTILITY(U,$J,358.3,2950,0)
 ;;=A63.0^^7^84^59
 ;;^UTILITY(U,$J,358.3,2950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2950,1,3,0)
 ;;=3^Human Papilloma Virus Infection NOS
 ;;^UTILITY(U,$J,358.3,2950,1,4,0)
 ;;=4^A63.0
 ;;^UTILITY(U,$J,358.3,2950,2)
 ;;=^5000360
 ;;^UTILITY(U,$J,358.3,2951,0)
 ;;=Z91.14^^7^84^60
 ;;^UTILITY(U,$J,358.3,2951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2951,1,3,0)
 ;;=3^Hx of Past Medication Noncompliance
 ;;^UTILITY(U,$J,358.3,2951,1,4,0)
 ;;=4^Z91.14
 ;;^UTILITY(U,$J,358.3,2951,2)
 ;;=^5063616
 ;;^UTILITY(U,$J,358.3,2952,0)
 ;;=E78.5^^7^84^61
 ;;^UTILITY(U,$J,358.3,2952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2952,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,2952,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,2952,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,2953,0)
 ;;=I10.^^7^84^62
 ;;^UTILITY(U,$J,358.3,2953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2953,1,3,0)
 ;;=3^Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,2953,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,2953,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,2954,0)
 ;;=E29.1^^7^84^92
 ;;^UTILITY(U,$J,358.3,2954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2954,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,2954,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,2954,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,2955,0)
 ;;=C46.7^^7^84^63
 ;;^UTILITY(U,$J,358.3,2955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2955,1,3,0)
 ;;=3^Kaposi's Sarcoma NEC
 ;;^UTILITY(U,$J,358.3,2955,1,4,0)
 ;;=4^C46.7
 ;;^UTILITY(U,$J,358.3,2955,2)
 ;;=^5133326
 ;;^UTILITY(U,$J,358.3,2956,0)
 ;;=C46.0^^7^84^64
 ;;^UTILITY(U,$J,358.3,2956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2956,1,3,0)
 ;;=3^Kaposi's Sarcoma,Skin
 ;;^UTILITY(U,$J,358.3,2956,1,4,0)
 ;;=4^C46.0
 ;;^UTILITY(U,$J,358.3,2956,2)
 ;;=^5001100
 ;;^UTILITY(U,$J,358.3,2957,0)
 ;;=K13.3^^7^84^65
 ;;^UTILITY(U,$J,358.3,2957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2957,1,3,0)
 ;;=3^Leukoplakia,Oral Hairy
 ;;^UTILITY(U,$J,358.3,2957,1,4,0)
 ;;=4^K13.3
 ;;^UTILITY(U,$J,358.3,2957,2)
 ;;=^5008493
 ;;^UTILITY(U,$J,358.3,2958,0)
 ;;=R53.81^^7^84^67
 ;;^UTILITY(U,$J,358.3,2958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2958,1,3,0)
 ;;=3^Malaise
 ;;^UTILITY(U,$J,358.3,2958,1,4,0)
 ;;=4^R53.81
 ;;^UTILITY(U,$J,358.3,2958,2)
 ;;=^5019518
 ;;^UTILITY(U,$J,358.3,2959,0)
 ;;=A31.0^^7^84^68
 ;;^UTILITY(U,$J,358.3,2959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2959,1,3,0)
 ;;=3^Mycobacteria,Atypical,Pulmonary
 ;;^UTILITY(U,$J,358.3,2959,1,4,0)
 ;;=4^A31.0
 ;;^UTILITY(U,$J,358.3,2959,2)
 ;;=^5000149
 ;;^UTILITY(U,$J,358.3,2960,0)
 ;;=A31.8^^7^84^69
 ;;^UTILITY(U,$J,358.3,2960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,2960,1,3,0)
 ;;=3^Mycobacterium,Non-Tuberculosis NEC
 ;;^UTILITY(U,$J,358.3,2960,1,4,0)
 ;;=4^A31.8
 ;;^UTILITY(U,$J,358.3,2960,2)
 ;;=^5000152
 ;;^UTILITY(U,$J,358.3,2961,0)
 ;;=A15.9^^7^84^70
 ;;^UTILITY(U,$J,358.3,2961,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI07D
